1-(2-morpholin-4-ylphenyl)ethanone O-methyloxime 在
镍 作用下,
以
氨 、 甲醇 为溶剂,
反应 11.0h,
以to give 1.1 g of the title compound的产率得到1-(2-morpholin-4-ylphenyl)ethanamine
参考文献:
名称:
Cyanoamidine P2X7 antagonists for the treatment of pain
Cyanoamidine P2X7 antagonists for the treatment of pain
申请人:Carroll A. William
公开号:US20060025614A1
公开(公告)日:2006-02-02
Novel cyanoamidines compounds of formula (I) and (II)
and their derivatives wherein R
1
-R
12
are as defined in the specification act as antagonists of the P2X
7
receptor. These compounds are particularly useful in the treatment of pain, inflammation and neurodegeneration states.
Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses
申请人:Masson Christophe
公开号:US20060079696A1
公开(公告)日:2006-04-13
This invention relates to poly-substituted derivatives of the N-(benzyl)phenylacetamide type, pharmaceutical compositions comprising same, therapeutic uses thereof, more particularly in the fields of human and animal health. This invention also relates to a process for the preparation of such derivatives.
[EN] CYANOAMIDINE P2X7 ANTAGONISTS FOR THE TREATMENT OF PAIN<br/>[FR] CYANOAMIDINES ANTAGONISTES DE P2X7 POUR LE TRAITEMENT DE LA DOULEUR
申请人:ABBOTT LAB
公开号:WO2006017406A1
公开(公告)日:2006-02-16
cyanoamidines compounds of formula (I) and (II) and their derivatives wherein R1 - R12 are as defined in the specification act as antagonists of the P2X7 receptor. These compounds are particularly useful in the treatment of pain, inflammation and neurodegeneration states.
[EN] SUBSTITUTED N-(BENZYL)PHENYLACETAMIDE DERIVATIVE COMPOUNDS, PREPARATION METHOD THEREOF AND USES OF SAME<br/>[FR] COMPOSES DERIVES DE N-(BENZYL)PHENYLACETAMIDE SUBSTITUES, PREPARATION ET UTILISATIONS
申请人:GENFIT
公开号:WO2006035157A2
公开(公告)日:2006-04-06
La présente invention concerne des dérivés du type N-(benzyl)phénylacétamide poly- substitués de formule (I); les compositions pharmaceutiques les comprenant, leurs applications thérapeutiques comme ligands de PPAR, notamment dans les domaines de la santé humaine et animale pour le traitement des dérèglements du métabolisme lipidique et/ou glucidique. La présente invention a également trait a un procédé de préparation de ces dérivés.